299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details
臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05601778 (ClinicalTrials.gov) | December 6, 2022 | 27/10/2022 | A Study of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis | Phase 2 Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-cystic Fibrosis Bronchiectasis | Non-cystic Fibrosis Bronchiectasis (NCFBE) | Drug: HSK31858;Drug: placebo | Haisco Pharmaceutical Group Co., Ltd. | NULL | Recruiting | 18 Years | N/A | All | 210 | Phase 2 | China |